Overview
FBLG market data
Price History
FBLG price chart · 1M
- O
- 1.01
- H
- 1.03
- L
- 0.999800
- C
- 1.00
- Vol
- 2,983.00
Daily history from Jan 31, 2024
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $1.01
- Previous Close
- $0.97
- Day High
- $1.03
- Day Low
- $1.00
- 52 Week High
- $9.47
- 52 Week Low
- $0.63
- 7 Day Return
- -5.33%
- 30 Day Return
- -31.73%
- 90 Day Return
- +22.36%
- 1 Year Return
- -88.99%
- Daily Notional Volume
- $3K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$8.35 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.83 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.62 – $9.65 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $6.7M · P/B 2.43.
Company News
10 captured
8-K filing — FibroBiologics, Inc. (FBLG)SEC EDGAR ·
EXCLUSIVE: FibroBiologics Files Patent Application For Cell-Based Alternative to GLP-1 InjectionsBenzinga ·
FibroBiologics Receives European Patent Titled Methods Of Enhancing Fibroblast Therapeutic ActivityBenzinga ·